JP2005521650A5 - - Google Patents

Download PDF

Info

Publication number
JP2005521650A5
JP2005521650A5 JP2003559997A JP2003559997A JP2005521650A5 JP 2005521650 A5 JP2005521650 A5 JP 2005521650A5 JP 2003559997 A JP2003559997 A JP 2003559997A JP 2003559997 A JP2003559997 A JP 2003559997A JP 2005521650 A5 JP2005521650 A5 JP 2005521650A5
Authority
JP
Japan
Prior art keywords
pyrazinyl
methoxy
benzenesulfonamide
dichloro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003559997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005521650A (ja
JP4504021B2 (ja
Filing date
Publication date
Priority claimed from SE0200119A external-priority patent/SE0200119D0/xx
Priority claimed from SE0201857A external-priority patent/SE0201857D0/xx
Application filed filed Critical
Priority claimed from PCT/SE2003/000041 external-priority patent/WO2003059893A1/en
Publication of JP2005521650A publication Critical patent/JP2005521650A/ja
Publication of JP2005521650A5 publication Critical patent/JP2005521650A5/ja
Application granted granted Critical
Publication of JP4504021B2 publication Critical patent/JP4504021B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003559997A 2002-01-16 2003-01-14 N−ピラジニル−フェニルスルホンアミド、およびケモカイン介在疾患の処置におけるそれらの使用 Expired - Fee Related JP4504021B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200119A SE0200119D0 (sv) 2002-01-16 2002-01-16 Novel compounds
SE0201857A SE0201857D0 (sv) 2002-06-17 2002-06-17 Novel compounds
PCT/SE2003/000041 WO2003059893A1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases

Publications (3)

Publication Number Publication Date
JP2005521650A JP2005521650A (ja) 2005-07-21
JP2005521650A5 true JP2005521650A5 (enExample) 2006-03-02
JP4504021B2 JP4504021B2 (ja) 2010-07-14

Family

ID=26655657

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003559997A Expired - Fee Related JP4504021B2 (ja) 2002-01-16 2003-01-14 N−ピラジニル−フェニルスルホンアミド、およびケモカイン介在疾患の処置におけるそれらの使用

Country Status (21)

Country Link
US (2) US7662825B2 (enExample)
EP (1) EP1467976B1 (enExample)
JP (1) JP4504021B2 (enExample)
KR (1) KR20040073566A (enExample)
CN (1) CN100357275C (enExample)
AR (1) AR038179A1 (enExample)
AT (1) ATE534635T1 (enExample)
AU (1) AU2003201802A1 (enExample)
BR (1) BR0306922A (enExample)
CA (1) CA2472204A1 (enExample)
CO (1) CO5640137A2 (enExample)
ES (1) ES2375107T3 (enExample)
IL (1) IL162678A0 (enExample)
IS (1) IS7348A (enExample)
MX (1) MXPA04006806A (enExample)
NO (1) NO20043370L (enExample)
NZ (1) NZ533750A (enExample)
PL (1) PL371432A1 (enExample)
RU (1) RU2312105C9 (enExample)
TW (1) TWI328007B (enExample)
WO (1) WO2003059893A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541563A4 (en) * 2002-07-10 2007-11-07 Ono Pharmaceutical Co ANTAGONIST OF CCR4 AND CORRESPONDING MEDICINAL USE
GB0217431D0 (en) 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
WO2004018435A1 (en) 2002-08-24 2004-03-04 Astrazeneca Ab Pyrimidine derivatives as modulators of chemokine receptor activity
SE0301653D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0302304D0 (sv) * 2003-08-27 2003-08-27 Astrazeneca Ab Novel compounds
EP1661889A4 (en) * 2003-09-05 2009-08-05 Ono Pharmaceutical Co ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
GB0401269D0 (en) * 2004-01-21 2004-02-25 Astrazeneca Ab Compounds
CA2576993C (en) 2004-08-12 2013-09-24 Amgen Inc. Bisaryl-sulfonamides
RU2408587C2 (ru) 2004-08-24 2011-01-10 Астразенека Аб Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
TW200800921A (en) * 2005-09-19 2008-01-01 Astrazeneca Ab Novel compounds
US20090182142A1 (en) * 2005-12-02 2009-07-16 Shigeru Furukubo Aromatic Compound
EP1970373A1 (en) * 2005-12-02 2008-09-17 Mitsubishi Tanabe Pharma Corporation Alicyclic heterocyclic compound
TW200730512A (en) * 2005-12-12 2007-08-16 Astrazeneca Ab Novel compounds
GB0526255D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
JP5140154B2 (ja) 2007-06-27 2013-02-06 アストラゼネカ・アクチエボラーグ ピラジノン誘導体および肺疾患の処置におけるそれらの使用
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
PT2374802E (pt) 2008-11-10 2014-07-10 Kyowa Hakko Kirin Co Ltd Inibidor de produção de quinurenina
PL2421829T3 (pl) * 2009-04-22 2016-03-31 Axikin Pharmaceuticals Inc 2,5-dipodstawione arylosulfonamidy jako antagoniści CCR3
TWI535442B (zh) 2010-05-10 2016-06-01 Kyowa Hakko Kirin Co Ltd A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
ES2655090T3 (es) * 2010-12-16 2018-02-16 Allergan, Inc. Derivados de 1,2-bis-sulfonamida como moduladores de receptores de quimiocinas
WO2013069765A1 (ja) 2011-11-09 2013-05-16 協和発酵キリン株式会社 含窒素複素環化合物
JP6327803B2 (ja) * 2013-07-09 2018-05-23 久慶 ▲ふく▼楊 大出力高効率単相多極発電機
CN106008418A (zh) * 2016-05-20 2016-10-12 厦门大学 一种5-氨甲基-2-呋喃甲醇的合成方法
SG11202007072RA (en) * 2018-01-26 2020-08-28 Rapt Therapeutics Inc Chemokine receptor modulators and uses thereof
CN113069446B (zh) * 2021-03-01 2022-12-02 中山亿维迪科技有限公司 El102在制备治疗新型冠状病毒所致疾病的药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US143024A (en) * 1873-09-23 Improvement in clothes-pins
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
GB9504854D0 (en) * 1994-03-31 1995-04-26 Zeneca Ltd Nitrogen derivatives
CA2162630C (en) 1994-11-25 2007-05-01 Volker Breu Sulfonamides
GB2295616A (en) * 1994-12-01 1996-06-05 Zeneca Ltd N-Diazine-benzenesulphonamide derivatives as endothelin receptor antagonists
GB9512697D0 (en) 1995-06-22 1995-08-23 Zeneca Ltd Heterocyclic compounds
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ATE416772T1 (de) 1998-07-06 2008-12-15 Bristol Myers Squibb Co Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
WO2001044239A2 (en) 1999-12-15 2001-06-21 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ATE312096T1 (de) 2001-12-18 2005-12-15 Neue verbindungen
EP1541563A4 (en) 2002-07-10 2007-11-07 Ono Pharmaceutical Co ANTAGONIST OF CCR4 AND CORRESPONDING MEDICINAL USE
SE0301650D0 (sv) 2003-06-04 2003-06-04 Astrazeneca Ab Novel compounds
SE0301654D0 (sv) 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0301653D0 (sv) 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0302304D0 (sv) 2003-08-27 2003-08-27 Astrazeneca Ab Novel compounds
TW200800921A (en) 2005-09-19 2008-01-01 Astrazeneca Ab Novel compounds
TW200730512A (en) 2005-12-12 2007-08-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2005521650A5 (enExample)
RU2312105C9 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2005511543A5 (enExample)
JP2005538955A5 (enExample)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2008516974A5 (enExample)
JP2021504443A5 (enExample)
JP2017537948A5 (enExample)
JP2004521087A5 (enExample)
JP2010505809A5 (enExample)
JP2004524301A5 (enExample)
JP2007502806A5 (enExample)
JP2007511485A5 (enExample)
JP2004504301A5 (enExample)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2007186518A5 (enExample)
KR20040015174A (ko) 복소환 유도체 및 의약
JP2007519692A5 (enExample)
JP4915715B2 (ja) フェニルピリダジン誘導体及びこれを含有する医薬
JP2014525937A5 (enExample)
JP2008505171A5 (enExample)
JP2006506380A5 (enExample)
JP2006508987A5 (enExample)
CN101918395A (zh) 三唑联噁二唑衍生物